Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Expedia announces partnership with Meta′s Muse (SeekingAlpha) +++ EXPEDIA Aktie +5,18%

AURORA CANNABIS Aktie

 >AURORA CANNABIS Aktienkurs 
3.7 EUR    +5.4%    (TradegateBSX)
Ask: 3.756 EUR / 300 Stück
Bid: 3.694 EUR / 300 Stück
Tagesumsatz: 11747 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
Aktie über LYNX handeln
>AURORA CANNABIS Performance
1 Woche: +7,1%
1 Monat: +4,2%
3 Monate: +35,7%
6 Monate: +25,2%
1 Jahr: -18,6%
laufendes Jahr: -5,0%
>AURORA CANNABIS Aktie
Name:  AURORA CANNABIS
Land:  Kanada
Sektor:  Gesundheit
ISIN/ Wkn:  CA05156X8504 / A4ZZ0W
Symbol/ Ticker:  21P (Frankfurt) / ACB (NASDAQ)
Kürzel:  FRA:21P, ETR:21P, 21P:GR, NASDAQ:ACB
Index:  -
Profil:  Aurora Cannabis Inc. is a Canadian cannabis company focused on the production, distribution, and sale of cannabis and cannabis-derived products in Canada and international markets. Aurora Cannabis Inc. serves both medical and consumer segments with o..
>Volltext..
Marktkapitalisierung:  217.76 Mio. EUR
Unternehmenswert:  139.89 Mio. EUR
Umsatz:  177.83 Mio. EUR
EBITDA:  -93.65 Mio. EUR
Nettogewinn:  -67.78 Mio. EUR
Gewinn je Aktie:  -1.19 EUR
Schulden:  13.9 Mio. EUR
Liquide Mittel:  72.57 Mio. EUR
Operativer Cashflow:  -17.21 Mio. EUR
Bargeldquote:  2.03
Umsatzwachstum:  -19.85%
Gewinnwachstum:  -461.77%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel -
Suchwörter:  AURORA CANNABIS
Letzte Datenerhebung:  22.09.26
>Kennzahlen
Aktien/ Unternehmen:
Aktien: 64.84 Mio. St.
Frei handelbar: 99.38%
Rückkaufquote: -4.64%
Mitarbeiter: 1028
Umsatz/Mitarb.: 0.2 Mio. EUR
Analysten:
Analystenrating: Buy
Kursziel: -0.05%
Bewertung:
KGV: -
KGV lG: -
KUV: 1.16
KBV: 0.65
PEG-Ratio: -0.01
EV/EBITDA: -
Rentabilität:
Bruttomarge: 9.75%
Gewinnmarge: -13.09%
Operative Marge: -56.79%
Managementeffizenz:
Gesamtkaprendite: -5.21%
Eigenkaprendite: -7.04%
>Peer Group
Gesundheit, Cannabis- Produkte
 
21.09.26 - 19:21
Aurora Cannabis extends gains for seventh straight session (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
16.09.26 - 13:16
Aurora Cannabis Provides Business Update; Accretive Acquisition of Safari Flower Company and Leading European Performance Expected to Fuel International Growth in the Fiscal Second Quarter 2027 and Beyond (PR Newswire)
 
NASDAQ| TSX: ACB Re-affirms FY27 Q2 guidance for sequential growth in quarterly net revenue and adjusted EBITDA1 Following the receipt of EU-GMP certification in July, Safari Flower Company is expected to contribute incremental net revenue and adjusted EBITDA1 Continued strong performance......
14.09.26 - 21:48
Aurora Cannabis says Curaleaf offer undervalues company (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
14.09.26 - 20:18
Aurora Cannabis Refutes Curaleaf′s Latest Attempt To Distract Shareholders From The Facts (PR Newswire)
 
NASDAQ | TSX: ACB Curaleaf's announcement is a desperate effort to shift attention away from the fundamental issue facing shareholders: its inadequate hostile bid undervalues Aurora. Curaleaf's attempt to fabricate issues ignores the reality of its own balance sheet: more than $1 billion......
09.09.26 - 13:06
Aurora Appoints Seasoned Biopharmaceutical Executive to Lead Commercial Acceleration of Global Medical Cannabis Business (PR Newswire)
 
EDMONTON, AB, Sept. 9, 2026 /PRNewswire/ -- Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, announces Faris El Refaie, a biopharmaceutical leader with 25 years of experience, will join the company as Executive Vice President,......
02.09.26 - 22:18
Aurora Cannabis Board Recommends Rejecting Curaleaf Bid (Bloomberg)
 
Aurora Cannabis CEO Miguel Martin called a takeover bid from cannabis company Curaleaf 'inadequate' and said that it was not in shareholder's best interest after the company's board unanimously rejected the offer. Martin said that he is not against offers on principle and would recommend going with another bid if it had the right value and structure for shareholders. (Source: Bloomberg)...
02.09.26 - 19:30
Aurora Cannabis board rejects offer from Curaleaf (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
02.09.26 - 15:18
Aurora Cannabis Calls Curaleaf Offer Inadequate, Urges Rejection (WSJ EN)
 
Aurora Cannabis is urging its shareholders to reject an unsolicited $272 million hostile takeover bid from Curaleaf Holdings....
02.09.26 - 13:06
Aurora Cannabis Urges Shareholders to REJECT Curaleaf′s Hostile Bid, Warning that it is Inadequate, Undervalues Aurora and Puts Shareholder Value and Future Upside at Risk (PR Newswire)
 
NASDAQ | TSX: ACB Curaleaf's hostile and opportunistic bid significantly undervalues Aurora, and aims to capture Aurora's assets at a discount Aurora is debt free and holds $149 million in cash1, Curaleaf carries over $1 billion in debt2, Aurora shareholders' own cash should not be used......
28.08.26 - 12:48
Is Aurora Cannabis Stock a Buy as Curaleaf Pushes a Hostile Takeover Bid? (Fool)
 
Aurora's turnaround could make Curaleaf's offer look too low....
24.08.26 - 21:51
Curaleaf Responds to Aurora Cannabis′ Latest Attempt to Deflect From Shareholder Value Creation (PR Newswire)
 
Aurora's selective statistics and misleading characterization of engagement do not obscure years of underperformance and lost shareholder value Curaleaf reiterates its willingness to meet anytime to discuss a deal in the best interests of shareholders STAMFORD, Conn., Aug. 24, 2026......
24.08.26 - 13:09
AURORA CANNABIS CORRECTS INACCURATE STATEMENTS MADE IN SUPPORT OF CURALEAF HOLDINGS′ HOSTILE BID (PR Newswire)
 
Curaleaf's self-serving portrayal of our business is an attempt to acquire Aurora's world class EU-GMP manufacturing facilities and global medical cannabis footprint at the lowest price possible Aurora's international strategy is working; net revenue is up 17%YOY Contrary to Curaleaf's......
20.08.26 - 14:00
Is Curaleaf Stock a Buy With Its Attempted Hostile Takeover of Aurora Cannabis Under Way? (Fool)
 
The U.S. company formally kicked off the bid for its peer across the northern border....
19.08.26 - 20:12
Tilray Jumps 6%, Canopy Growth Climbs 3%, Aurora Cannabis Gains 4%: Here’s Why TLRY Is Still Down 47% YTD (24/7 Wall St.)
 
Shares of Tilray Brands (NASDAQ:TLRY) are up 6% to $4.75 Wednesday afternoon, participating in a broad bid for beaten-down speculative names. The rally doesn't change the number that defines the year for Tilray. The stock is down 48% year to date (YTD), a figure that already includes today's gain. The TLRY stock bid appears tied ... Tilray Jumps 6%, Canopy Growth Climbs 3%, Aurora Cannabis Gains 4%: Here's Why TLRY Is Still Down 47% YTD...
19.08.26 - 19:48
Aurora Cannabis Furthers Global Medical Cannabis Growth with Accretive Acquisition of Internode Pharma Limited and HAP Pharma Limited, Expanding Distribution Access to the UK Medical Cannabis Market (PR Newswire)
 
EDMONTON, AB, Aug. 19, 2026 /PRNewswire/ -- Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, is pleased to announce that it has acquired Internode Pharma Limited, a licensed importer and wholesaler, and......
19.08.26 - 14:18
Aurora Cannabis confirms Curaleaf hostile takeover bid (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
19.08.26 - 14:12
Aurora Cannabis shareholders urged to wait on Curaleaf bid (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
19.08.26 - 13:06
AURORA CANNABIS INC. URGES SHAREHOLDERS TO TAKE NO ACTION AT THIS TIME IN RESPECT TO THE UNSOLICITED TAKE-OVER BID BY CURALEAF HOLDINGS, INC. (PR Newswire)
 
Curaleaf's decision to launch a hostile takeover bid is designed to pressure Aurora's shareholders into a short-term decision for the benefit of Curaleaf shareholders. Curaleaf's actions and comments reflect its objective: to acquire, at the lowest price possible, Aurora's market-leading......
18.08.26 - 14:30
Curaleaf launches $4/share takeover bid for Aurora Cannabis (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Werde nie so reich an Geist, dass arm Du würdest am Herzen! - Otto Ludwig
>Aktienauflistung | >Aktienscreener | >Aktienkennzahlen | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!